Arizona Bioscience News: Phoenix Biomedical Campus innovation; Aqualung Therapeutics to start trials; Omicron hospital surge

February 3, 2022

By brianpowell

Innovation and discovery at the Phoenix Biomedical Campus / Downtown Phoenix Inc.

The Phoenix Biomedical Campus, home to universities, hospital systems, research institutes, and companies, continues to evolve and grow.

The next Silicon Valley? These founders say this Arizona city is the best place to build a startup / Phoenix Business Journal (AZ Inno)

Despite there being more than 20 cities and towns spread out over the greater Phoenix metro area, a group of young founders say that Tempe is the best place to build a high-growth startup in the Valley.

5 cities emerging as future hubs for life sciences development / Bisnow

There is a new class of nascent life sciences centers such as Phoenix beginning to take shape that could become centers for investment and development.

Tucson startup looks to human trials for drug to treat lung inflammation / Arizona Daily Star

Aqualung Therapeutics, a Tucson-based drug startup headed by a University of Arizona pulmonologist, has won a major investment to help take its flagship drug into initial human clinical trials for treatment of life-threatening lung inflammation.

‘It’s still very real’: Omicron cases may have peaked in Arizona, but hospitals haven’t seen a slowdown / Arizona Republic

The January COVID-19 spike, most of it caused by the omicron variant, has led to the highest number of hospitalizations in this latest third wave of illness. Read more: Arizona ends 26-day streak of reporting more than 10,000 new COVID cases

Phoenix Children’s doctor: Croup becoming more common among kids with COVID-19 / KTAR

A doctor at Phoenix Children’s Hospital wants parents to be aware of a loud, barking-like cough known as croup, which causes swelling and inflammation of the upper part of a kid’s airways, that’s showing up among children infected with the omicron variant of COVID-19.

UA researchers pilot device for early detection of ovarian cancer / Arizona Daily Star

A team of scientists at the University of Arizona are in the process of developing a screening tool, called the falloposcope, that could aid in the early detection of ovarian cancer.

Upcoming Events

February 15: AZBioPEERS: Tales from the Road—How Local People Completed Successful Exits

March 1: A Sip of Science: Sequencing SARS-CoV-2 variants

March 2-3: Venture Madness

Sign up to receive Arizona Bioscience News weekly

Search the Arizona BioMap